Drug-related deaths in a university central hospital

European Journal of Clinical Pharmacology

Volumn 58, Issue 7, 2002, Pages 479-482

  Mohan, Rajiv R ^a   Possin, Daniel E ^a   Mohan, Rahul R ^a   Sinha, Sunilima ^a   Wilson, Steven E ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Adverse drug reaction; Anticoagulants; Antineoplastic agents; Drug related death

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CONTRAST MEDIUM; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DACARBAZINE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUDARABINE; FLUOROURACIL; HEPARIN; IBUPROFEN; IDARUBICIN; IFOSFAMIDE; MELPHALAN; NONSTEROID ANTIINFLAMMATORY AGENT; PROCARBAZINE; RETEPLASE; UNINDEXED DRUG; VINBLASTINE; WARFARIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CARDIOMYOPATHY; CHILD; CONTROLLED STUDY; DEATH; DEATH CERTIFICATE; DISEASE CLASSIFICATION; DRUG CLASSIFICATION; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART ARRHYTHMIA; HOSPITAL ADMISSION; HUMAN; HYPERKALEMIA; HYPOGLYCEMIA; IMMUNE DEFICIENCY; INCIDENCE; KIDNEY FAILURE; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; NEUROLEPTIC MALIGNANT SYNDROME; NEUTROPENIA; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS; SUICIDE; THROMBOCYTOPENIA; UNIVERSITY HOSPITAL; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; DEATH CERTIFICATES; DRUG INTERACTIONS; FEMALE; FINLAND; HOSPITAL MORTALITY; HOSPITALS, TEACHING; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MEDICATION ERRORS; MIDDLE AGED; PATIENT ADMISSION; PHARMACEUTICAL PREPARATIONS;

EID: 0036033644     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-002-0501-2     Document Type: Article

References (20)

1. Ferner RE (1992) Hazards, risks and reality. Br J Clin Pharmacol 33:125-128
2. World Health Organisation (1966) World Health Organisation Technical Report Series No. 425. International Drug Monitoring: The Role of the Hospital. World Health Organisation, Geneva, Switzerland
3. Moore N, Lecointre D, Noblet C, Mabille M (1998) Frequency and cost of serious adverse drug reactions in a department of general medicine. Br J Clin Pharmacol 45:301-308
4. Lagnaoui R, Moore N, Fach J, Longy-Boursier M, Bégaud B (2000) Adverse drug reactions in a department of systemic diseases-oriented internal medicine: Prevalence, incidence, direct costs and avoidability. Eur J Clin Pharmacol 55:181-186
5. Fattinger K, Roos M, Vergéres P, Holenstein C, Kind B, Masche U, Stocker D, Braunschweig S, Kullak-Ublick GA, Galeazzi RL, Follath F, Gasser T, Meier PJ (2000) Epidemiology of drug exposure and adverse drug reactions in two Swiss departments of internal medicine. Br J Clin Pharmacol 49:158-167
6. Ives TJ, Bentz EJ, Gwyther RE (1987) Drug-related admissions to a family medicine inpatient service. Arch Intern Med 147:1117-1120
7. Einarson TR (1993) Drug-related hospital admissions. Ann Pharmacother 27:832-840
8. Schneitman-McIntire O, Farnen TL, Gordon N, Chan J, Toy WA (1996) Medication misadventures resulting in emergency department visits at an HMO medical center. Am J Health Syst Pharm 53:1416-1422
9. Dennehy CE, Kishi DT, Louie C (1996) Drug-related illness in emergency department patients. Am J Health Syst Pharm 53:1422-1426
10. Malhotra S, Jain S, Pandhi P (2001) Drug-related visits to the medical emergency department: Prospective study from India. Int J Clin Pharmacol Ther 39:12-18
11. Ibáñez L, Laporte J-R, Carné X (1991) Adverse drug reactions leading to hospital admission. Drug Saf 6:450-459
12. Stoukides CA, D'Agostino PR, Kaufman MB (1993) Adverse drug reaction surveillance in an emergency room. Am J Hosp Pharm 50:712-714
13. Prince BS, Goetz CM, Rihn TL, Olsky M (1992) Drug-related emergency department visits and hospital admissions. Am J Hosp Pharm 49:1696-1700
14. Chyka PA (2001) How many deaths occur annually from adverse drug reactions in the United States? Am J Med 109:122-130
15. Zoppi M, Braunschweig S, Kuenzi UP, Maibach R, Hoigné R (2000) Incidence of lethal adverse drug reactions in the comprehensive hospital drug monitoring, a 20-year survey, 1974-1993, based on the data of Berne/St. Gallen. Eur J Clin Pharmacol 56:427-430
16. Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. JAMA 279:1200-1205
17. Caranasos GJ, May F, Steward RB, Cluff LE (1976) Drug-associated deaths of medical inpatients. Arch Intern Med 136:872-875
18. Porter J, Jick H (1977) Drug-related deaths among medical inpatients. JAMA 237:879-881
19. Ebbesen J, Buajodet I, Erikssen J, Brors O, Hillberg T, Svaar H, Sandvik L (2001) Drug related deaths in a department of internal medicine. Arch Int Med 161:2317-2323
20. Kelly WN (2001) Potential risks and prevention, part 1: Fatal adverse drug events. Am J Health Syst Pharm 58:1317-1324